(NASDAQ: IRTC) Irhythm Technologies's forecast annual revenue growth rate of 12.52% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.86%.
Irhythm Technologies's revenue in 2025 is $702,573,000.On average, 18 Wall Street analysts forecast IRTC's revenue for 2025 to be $23,872,774,006, with the lowest IRTC revenue forecast at $22,860,126,341, and the highest IRTC revenue forecast at $24,826,460,639. On average, 18 Wall Street analysts forecast IRTC's revenue for 2026 to be $27,932,386,024, with the lowest IRTC revenue forecast at $26,484,779,929, and the highest IRTC revenue forecast at $29,225,984,615.
In 2027, IRTC is forecast to generate $32,315,800,429 in revenue, with the lowest revenue forecast at $30,374,919,255 and the highest revenue forecast at $33,862,319,293.